02286nas a2200277   4500000000100000008004100001100001400042700001400056700001400070700001400084700001700098700001400115700001100129700001500140700001700155700001400172700001300186700001300199700001200212245013400224856005500358300000900413490000700422520156500429022001401994       2016                            d1 aStaples E1 aDziuban E1 aFischer M1 aCragan JD1 aRasmussen SA1 aCannon MJ1 aFrey M1 aRenquist C1 aLanciotti RS1 aMuñoz JL1 aPowers A1 aHonein M1 aMoore C00aInterim guidelines for the evaluation and testing of infants with possible congenital Zika virus infection - United States, 2016.  uhttp://www.cdc.gov/mmwr/volumes/65/wr/mm6503e3.htm  a63-70 v653 a<p>CDC has developed interim guidelines for health care providers in the United States who are caring for infants born to mothers who traveled to or resided in an area with Zika virus transmission during pregnancy. These guidelines include recommendations for the testing and management of these infants. Guidance is subject to change as more information becomes available; the latest information, including answers to commonly asked questions, can be found online (http://www.cdc.gov/zika). Pediatric health care providers should work closely with obstetric providers to identify infants whose mothers were potentially infected with Zika virus during pregnancy (based on travel to or residence in an area with Zika virus transmission [http://wwwnc.cdc.gov/travel/notices]), and review fetal ultrasounds and maternal testing for Zika virus infection (see Interim Guidelines for Pregnant Women During a Zika Virus Outbreak*) (1). Zika virus testing is recommended for 1) infants with microcephaly or intracranial calcifications born to women who traveled to or resided in an area with Zika virus transmission while pregnant; or 2) infants born to mothers with positive or inconclusive test results for Zika virus infection. For infants with laboratory evidence of a possible congenital Zika virus infection, additional clinical evaluation and follow-up is recommended. Health care providers should contact their state or territorial health department to facilitate testing. As an arboviral disease, Zika virus disease is a nationally notifiable condition.</p>
  a1545-861X